Zacks.com on MSN2mon
ChromaDex Corporation (CDXC) Hit a 52 Week High, Can the Run Continue?
S hares of ChromaDex (CDXC) have been strong performers lately, with the stock up 72.9% over the past month. The stock hit a new 52-week high of $6.18 in the previous session. ChromaDex has gained ...
Well+Good27d
‘I’m a Longevity Expert, and Here’s Everything You Need to Know About Anti-Aging NMN Supplements’
NMN—short for nicotinamide mononucleotide or beta-nicotinamide mononucleotide—is one of the main precursors to NAD+, an essential enzyme partly responsible for DNA repair, cell growth and ...
Investing1mon
ChromaDex maintains Buy rating on recent agreement
On Friday, Roth/MKM maintained a Buy rating and an $8.00 price target for ChromaDex (NASDAQ: CDXC) shares, following a recent amendment to its agreement with Dartmouth College. The stock has ...
Yahoo Finance1mon
Even though ChromaDex (NASDAQ:CDXC) has lost US$73m market cap in last 7 days, shareholders are still up 389% over 1 year
It's been a soft week for ChromaDex Corporation (NASDAQ:CDXC) shares, which are down 13%. But that isn't a problem when you consider how the share price has soared over the last year. In fact, it is ...
Investing1mon
ChromaDex appoints Crowe as new auditor
In a recent filing with the Securities and Exchange Commission, ChromaDex Corp. (NASDAQ:CDXC), a company specializing in medicinal chemicals and botanical products that has delivered an impressive 343 ...